AZD-1208

N/A

Report date: 2022/07/04 19:38:02

NME

Base Information

Drug NameAZD-1208

Drug Alias NameAZD-1208

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProto-oncogene serine/threonine-protein kinase Pim-1 inhibitorsSerine/threonine-protein kinase pim-2 inhibitorsSerine/threonine-protein kinase pim-3 inhibitors

TargetsSerine/threonine-protein kinase pim-2Proto-oncogene serine/threonine-protein kinase Pim-1Serine/threonine-protein kinase pim-3

Therapy Area/IndicationsSolid tumoursLymphomaLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited StatesUnited Kingdom +[4]

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAstrazeneca Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAstrazeneca Plc

Active IndicationsN/A

Inactive IndicationsSolid tumoursLymphomaLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A